Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Home Capital Group Inc T.HCG

Home Capital Group Inc. is a Canada-based holding company that operates through its principal subsidiary, Home Trust Company (Home Trust). Home Trust is a federally regulated trust company offering residential and non-residential mortgage lending, securitization of residential mortgage products, consumer lending and credit card services. In addition, Home Trust and its wholly owned subsidiary... see more

TSX:HCG - Post Discussion

Home Capital Group Inc > Voted my 1,500 shares in favour of plan of arrangement
View:
Post by Galove on Jan 22, 2023 11:24am

Voted my 1,500 shares in favour of plan of arrangement

I took the time to read the Management Information Circular and here is a timeline summary from a date perspective. In short, I think the offer of $44.00 share is reasonable given it was shopped around to 38 potental buys and only three (3) came foraward, but neither offered a higher bid.

Key points from pages 24-29. Sadly, when I post the content the formating is not the greatest, but the dates contains the main points.

22 April 2022: HCG closing price $34.81.
25 April 2022: Received purchase offer of $44.00 per share (26% premium) from Smith Financial Corporation (SFC).
4 May 2022: Issued financial results for Q1 Mortgage originations increased by 72.5%. Q over Q decrease in net income of 30.7%
Closing price $29.60, Book Value (BV) $37.45. 
6 - 13 May 2022: Special Committee responded with counter proposal $47.00 per share requesting response by 13 May.
SFC did not respond, and Chair was authorized by board to notify SFC company was not forsale.
16 May 2022: HCG Closing price $27.98 representing 20% decrease. 
18 May - 3 August 2022: Average share closing price $26.64, BV $38.72.
4 August 2022: HCG announces 115 million Substantial Issuer Bid (SIB).
Price set between $25.20 and $28.60. SIB would commence 8 August and expire 13 September 2022.
8 August 2022 Closing price $27.69.
9 August 2022: SFC proposes $37.50 per share (initial offer). SFC requesting response 12 August 2022.
10 - 14 August 2022: HCG Special Committee and Board Torys LLP and Financial Adivsers to discuss initial SFC proposal. 
14 August 2022: HCG closing price $28.47.
15 August 2022: HCG issues press release of an unsolicited expression of interest and concludes not in best
interest of share holders. HCG closing price $31.28 (9% increase).
19 September 2022: HCG closing price $28.89. BV $40.32
20 September 2022: SFC second proposal of $41.00 per share requesting response by 23 September. 
21 September - 2 October 2022: Financial advisors worked with HCG to update their analysis.
2 - 7 October 2022: Parties negotiated terms of second SFC proposal which included a go-shop period.
7 October - 3 November 2022: Parties conduct due diligence.
2 November 2022: SFC requests extension of exclusivity period to 14 November. Granted 6 November.
8 November 2022: HCG reports Q3 with impairment of $9.4 million in non-interest expenses and net income
decreased by 43.5% compared to Q3/2021 due to rapidly rising interest rates. 
13 November 2022: Board met with financial advisors to discuss fundamental value of company following Q3 in
which the board concluded the company value remained unchanged.
16 November 2022: Discussion between SFC and HCG Chair and transaction proceeded at $44.00 per share.
16 - 19 November 2022: HCG and SFC concludes due diligence.
18 November 2022: HCG closing price $27.05
20 November 2022: Board meets to review terms and conditions of agreement and fairness opinons. 
Shareholders should vote in favour of the arrangement.
21 November 2022: Press release announcing transaction prior to TSX opening. HCG closing price $42.50
 
Go-Shop Process: 38 potential buyers were contacted. Three companies entered into Confidentiality agreements with HCG.
HCG did not receive any Acquisition Proposal during the Go-Shop Period.
Required Shareholder Approval: 66 2/3% of votes in favour for arrangement to proceed.
Comment by Stooge on Feb 07, 2023 1:22pm
Voted my 7,000 shares AGAINST the buyout. Regardless of how I might try to analyse the prospects I trust Smith, as a sophisticated investor, when he determined it is a buy at $44 and put big money on his analysis.
Comment by Galove on Feb 08, 2023 2:33pm
Fair enough! There are always other companies that are good investments.  I am waiting to see how GSY fairs when they report next week. I would like to purchase shares around $95.00. If HCG did not receive the buyout offer it would of been a no brainer to own more shares when it traded under $24.00. I took a position of 500 shares on 21 October and continued adding in blocks of 500 on the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities